diagnostic tests

Nasdaq

MedTech

Caris Life Sciences ups IPO to raise $494M

The cancer testing company claimed a valuation of about $5.9 billion, while selling 23.5 million shares under the Nasdaq ticker "CAI" at $21 apiece.

Conor Hale Jun 18, 2025 11:00am

Dark blue graphic featuring a stylized molecular structure and DNA sequencing patterns in the background The title THE TO

Inside Fierce Medtech's Fierce 15

Jun 13, 2025 8:47am

blood test vial

Quest Diagnostics taps MD Anderson for cancer risk blood test

Jun 10, 2025 2:11pm

Fierce Medtech Fierce 15

Introducing Fierce Medtech's Fierce 15

Jun 2, 2025 3:00am

A hand with a blue glove reaches for the middle one of 12 vials with brightly-colored tops The vials appear to contain blood

Federal judge blocks FDA's regulation of lab-developed tests

Apr 1, 2025 11:35am

artificial intelligence chip

Quest Diagnostics teams up with Google Cloud on gen AI

Mar 18, 2025 2:00pm